Patient P-01550

Synthetic patientNBL-101 · Day 111 · 65–74 · F · baseline S08Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Deteriorating

GI state

Improving

Inflammatory state

Improving

Nutritional resilience

Favorable

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S08

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability-19
Toxicity+12
Inflammatory activity-6
Nutritional resilience+4
Treatment adherence-4

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

0/100

improving · -5.3 vs previous 14 d

Toxicity

Blood

23.7/100

stable · -0.0 vs previous 14 d

Sleep quality

Wearable

44.3/100

stable · -0.2 vs previous 14 d

Energy level

Daily log

7.7/10

stable · +0.1 vs previous 14 d

Stress level

Daily log

3.3/10

improving · -0.3 vs previous 14 d

Steps

Wearable

4,859

stable · +35 vs previous 14 d

Adherence

Companion

85.2 %

stable · -1.9 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards restoration · 107 from the failing basin, 22 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Keep alcohol low
GI +2.7 next day on high-intake days · n 18

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
+2.7detractor · 60%
Dietary fat load
+2.4no signal · 51%
Simple carbohydrates
-1.6no signal · 36%
Spicy / capsaicin
+1.5no signal · 34%
Insoluble fibre
-1no signal · 23%
Histamine load
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
Inflammatory signalling ↓35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 38 ms, trending down
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

CYP2D6 Poor metabolizer
Higher exposure at standard dose

Microbiome

Shannon diversity 3.2 · butyrate capacity 55/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 36 ms
Sleep: 6.3 h
Steps: 5,407
Resting HR: 54 bpm

Daily log: GI score 0, nutritional resilience 71, adherence 85.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01766	43%	S05	AD-05	no change	90
P-01804	28%	S19	AD-05	improved	61
P-01495	43%	S07	BR-03	improved	85
P-01329	42%	S08	BR-03	improved	79
P-01677	36%	S05	BR-03	no change	86
P-01654	49%	S08	CR-01	improved	85
P-01430	25%	S05	CR-01	improved	54
P-01479	36%	S15	DT-01	improved	84
P-01855	32%	S04	DT-01	improved	73
P-01724	29%	S10	DT-01	improved	63
P-01767	28%	S14	DT-01	no change	63
P-01346	26%	S12	DT-01	improved	52